Ryo Taguchi

What is he best known for?

The fields of study he is best known for:

• Enzyme
• Gene
• Biochemistry

His main research concerns Biochemistry, Mass spectrometry, Analytical chemistry, Tandem mass spectrometry and Inflammation. In his study, Ryo Taguchi carries out multidisciplinary Biochemistry and MBOAT research. His study involves Mass spectrometry imaging and Mass spectrum, a branch of Mass spectrometry.

His work in the fields of Analytical chemistry, such as Quadrupole ion trap, Ion trap and Electrospray ionization, intersects with other areas such as Experimental data. His work in Tandem mass spectrometry addresses issues such as Lipidomics, which are connected to fields such as Phospholipid, High-performance liquid chromatography, Molecular mass, Reversed-phase chromatography and Protein mass spectrometry. His Inflammation study incorporates themes from Eicosapentaenoic acid, Docosahexaenoic acid, Anti-inflammatory and Lung.

His most cited work include:

• MassBank: a public repository for sharing mass spectral data for life sciences (1123 citations)
• Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. (330 citations)
• The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza (266 citations)

What are the main themes of his work throughout his whole career to date?

Biochemistry, Chromatography, Cell biology, Phosphatidylcholine and Endocrinology are his primary areas of study. Biochemistry is a component of his Phosphatidylinositol, Phospholipase, Phospholipase C, Phospholipid and Enzyme studies. In his study, which falls under the umbrella issue of Chromatography, Metabolomics and Liquid chromatography–mass spectrometry is strongly linked to Lipidomics.

His Cell biology research is multidisciplinary, relying on both Phospholipase A2, Receptor and Lipid microdomain. His work carried out in the field of Phosphatidylcholine brings together such families of science as Acyltransferase and Sphingomyelin. His studies examine the connections between Endocrinology and genetics, as well as such issues in Internal medicine, with regards to Docosahexaenoic acid.

He most often published in these fields:

• Biochemistry (68.18%)
• Chromatography (17.53%)
• Cell biology (19.48%)

What were the highlights of his more recent work (between 2012-2018)?

• Biochemistry (68.18%)
• Cell biology (19.48%)
• Endocrinology (18.83%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Biochemistry, Cell biology, Endocrinology, Internal medicine and Phosphatidylcholine. His is doing research in Docosahexaenoic acid, Ceramide, Fatty acid, Fatty acid elongation and Sphingomyelin, both of which are found in Biochemistry. Ryo Taguchi combines subjects such as Phospholipase A2 and Receptor with his study of Cell biology.

Ryo Taguchi has researched Receptor in several fields, including Molecular biology, Endogeny and Glycosphingolipid. Ryo Taguchi interconnects Ejection fraction and Heart failure in the investigation of issues within Endocrinology. His Phosphatidylcholine research includes themes of Zellweger syndrome, Lipidology and Phosphatidylserine.

Between 2012 and 2018, his most popular works were:

• The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza (266 citations)
• Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production. (91 citations)
• Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease (80 citations)

In his most recent research, the most cited papers focused on:

• Enzyme
• Gene
• Biochemistry

His primary scientific interests are in Endocrinology, Internal medicine, Sphingolipid, Lipid signaling and Immunology. His Endocrinology research integrates issues from Phospholipase and Phosphatidylethanolamine. His Dilated cardiomyopathy and Steatosis study, which is part of a larger body of work in Internal medicine, is frequently linked to Nonalcoholic steatohepatitis and Hepatic lipid, bridging the gap between disciplines.

Ryo Taguchi has included themes like Immune system and Lipidomics in his Lipid signaling study. As a part of the same scientific family, Ryo Taguchi mostly works in the field of Immunology, focusing on Phospholipase A2 and, on occasion, Prostaglandin D2 and Receptor. His Lipid metabolism research is classified as research in Biochemistry.